Related Experiment Video
Updated: Sep 26, 2025

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
Toll-Like Receptor 4 in Pain: Bridging Molecules-to-Cells-to-Systems
Sanam Mustafa1,2, Samuel Evans3, Benjamin Barry3
1Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia. sanam.mustafa@adelaide.edu.au.
Abstract:
Pain impacts the lives of billions of people around the world - both directly and indirectly. It is complex and transcends beyond an unpleasant sensory experience to encompass emotional experiences. To date, there are no successful treatments for sufferers of chronic pain. Although opioids do not provide any benefit to chronic pain sufferers, they are still prescribed, often resulting in more complications such as hyperalgesia and dependence. In order to develop effective and safe medications to manage, and perhaps even treat pain, it is important to evaluate novel contributors to pain pathologies. As such, in this chapter we review the role of Toll-like receptor 4, a receptor of the innate immune system, that continues to gain substantial attention in the field of pain research. Positioned in the nexus of the neuro and immune systems, TLR4 may provide one of the missing pieces in understanding the complexities of pain. Here we consider how TLR4 enables a mechanistical understanding of pain as a multidimensional biopsychosocial state from molecules to cells to systems and back again.
More Related Videos
Related Concept Videos
Nociception
Analgesia and Pain Management
Pain
Opioid Receptors: Overview
Signal Transduction: Overview
Typically, signal transduction involves three...
Thermosensation

